708 related articles for article (PubMed ID: 17196348)
1. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
[TBL] [Abstract][Full Text] [Related]
2. Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA.
Cai C; Mao S; Germershaus O; Schaper A; Rytting E; Chen D; Kissel T
J Microencapsul; 2009 Jun; 26(4):334-45. PubMed ID: 18720198
[TBL] [Abstract][Full Text] [Related]
3. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
4. The influence of surfactant on PLGA microsphere glass transition and water sorption: remodeling the surface morphology to attenuate the burst release.
Bouissou C; Rouse JJ; Price R; van der Walle CF
Pharm Res; 2006 Jun; 23(6):1295-305. PubMed ID: 16715359
[TBL] [Abstract][Full Text] [Related]
5. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism.
Berkland C; Pollauf E; Raman C; Silverman R; Kim K'; Pack DW
J Pharm Sci; 2007 May; 96(5):1176-91. PubMed ID: 17455338
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics.
Bittner B; Morlock M; Koll H; Winter G; Kissel T
Eur J Pharm Biopharm; 1998 May; 45(3):295-305. PubMed ID: 9653634
[TBL] [Abstract][Full Text] [Related]
7. Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres.
Kim TH; Park TG
Int J Pharm; 2004 Mar; 271(1-2):207-14. PubMed ID: 15129987
[TBL] [Abstract][Full Text] [Related]
8. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
[TBL] [Abstract][Full Text] [Related]
9. Quantitative three-dimensional analysis of poly (lactic-co-glycolic acid) microsphere using hard X-ray nano-tomography revealed correlation between structural parameters and drug burst release.
Huang X; Li N; Wang D; Luo Y; Wu Z; Guo Z; Jin Q; Liu Z; Huang Y; Zhang Y; Wu C
J Pharm Biomed Anal; 2015 Aug; 112():43-9. PubMed ID: 25951620
[TBL] [Abstract][Full Text] [Related]
10. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
11. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
[TBL] [Abstract][Full Text] [Related]
12. Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approach.
Gu B; Burgess DJ
Int J Pharm; 2015 Nov; 495(1):393-403. PubMed ID: 26325309
[TBL] [Abstract][Full Text] [Related]
13. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
14. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
Song X; Song SK; Zhao P; Wei LM; Jiao HS
Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
[TBL] [Abstract][Full Text] [Related]
15. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
16. Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months.
Kazazi-Hyseni F; Landin M; Lathuile A; Veldhuis GJ; Rahimian S; Hennink WE; Kok RJ; van Nostrum CF
Pharm Res; 2014 Oct; 31(10):2844-56. PubMed ID: 24825756
[TBL] [Abstract][Full Text] [Related]
17. Development of protein delivery microsphere system by a novel S/O/O/W multi-emulsion.
Yuan W; Wu F; Guo M; Jin T
Eur J Pharm Sci; 2009 Feb; 36(2-3):212-8. PubMed ID: 18832030
[TBL] [Abstract][Full Text] [Related]
18. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite.
Ho ML; Fu YC; Wang GJ; Chen HT; Chang JK; Tsai TH; Wang CK
J Control Release; 2008 Jun; 128(2):142-8. PubMed ID: 18436324
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
20. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
